HRAS and familial pancreatic carcinoma: Mutant KRAS–SOS1–WT RAS allosteric signaling promotes growth of KRAS-mutated pancreatic cancer cell xenografts [77], but has not been assessed for mutant HRAS- or NRAS-dependent transformation.